These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting. Sharma S; Ehrlich M; Zhang M; Blobe GC; Henis YI Commun Biol; 2024 Jan; 7(1):112. PubMed ID: 38242992 [TBL] [Abstract][Full Text] [Related]
11. Raftlin is recruited by neuropilin-1 to the activated VEGFR2 complex to control proangiogenic signaling. Bayliss AL; Sundararaman A; Granet C; Mellor H Angiogenesis; 2020 Aug; 23(3):371-383. PubMed ID: 32274611 [TBL] [Abstract][Full Text] [Related]
12. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features. Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971 [TBL] [Abstract][Full Text] [Related]
13. Rhodocetin-αβ-induced neuropilin-1-cMet association triggers restructuring of matrix contacts in endothelial cells. Niland S; Ditkowski B; Parrandier D; Roth L; Augustin H; Eble JA Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):544-54. PubMed ID: 23288161 [TBL] [Abstract][Full Text] [Related]
14. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis. Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687 [TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity. Sulpice E; Plouët J; Bergé M; Allanic D; Tobelem G; Merkulova-Rainon T Blood; 2008 Feb; 111(4):2036-45. PubMed ID: 18065694 [TBL] [Abstract][Full Text] [Related]
16. Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1. Lake AC; Vassy R; Di Benedetto M; Lavigne D; Le Visage C; Perret GY; Letourneur D J Biol Chem; 2006 Dec; 281(49):37844-52. PubMed ID: 17028197 [TBL] [Abstract][Full Text] [Related]
17. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling. Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875 [TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity. Kawamura H; Li X; Harper SJ; Bates DO; Claesson-Welsh L Cancer Res; 2008 Jun; 68(12):4683-92. PubMed ID: 18559514 [TBL] [Abstract][Full Text] [Related]
19. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis. Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176 [TBL] [Abstract][Full Text] [Related]
20. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. Miao HQ; Soker S; Feiner L; Alonso JL; Raper JA; Klagsbrun M J Cell Biol; 1999 Jul; 146(1):233-42. PubMed ID: 10402473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]